Dr. Kozal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3801 Miranda Ave
Palo Alto, CA 94304Phone+1 650-374-9610
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1991 - 1994
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1988 - 1991
- University of Nebraska College of MedicineClass of 1988
Certifications & Licensure
- NE State Medical License 1990 - 2026
- CA State Medical License 1991 - 2025
- CT State Medical License 2000 - 2025
- TX State Medical License 1999 - 2025
- IA State Medical License 1995 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Pilot Study of a Raltegravir Based NRTI Sparing Regimen Start of enrollment: 2009 May 01
- Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay Start of enrollment: 2014 Jan 01
- Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects Start of enrollment: 2014 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1903 citationsCirculating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a c...Daniel D Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus
Plos One. 2015-10-14 - 39 citationsVirologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as ini...Mary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng, Michael J. Kozal, Richard M. Novak
HIV Clinical Trials. 2008-09-01 - 259 citationsLow-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z. Li, Roger Paredes, Heather J. Ribaudo, Evguenia S. Svarovskaia, Karin J. Metzner
JAMA. 2011-04-06
Journal Articles
- Fostemsavir in Adults with Multidrug-Resistant HIV-1 InfectionMichael Kozal, Edwin Dejesus, Cyril Llamoso, The New England Journal of Medicine
Other
- Fostemsavir in Adults with Multidrug-Resistant HIV-1 InfectionMichael Kozal, MD, The New England Journal of Medicine
https://www.doximity.com/articles/53c3f551-51dc-4278-9eda-95049ceeac02
UpToDate, Wolters Kluwer Health - 2012-12-06 - Fostemsavir in Adults with Multidrug-Resistant HIV-1 InfectionMichael Kozal, MD, New England Journal of Medicine
https://www.doximity.com/articles/53c3f551-51dc-4278-9eda-95049ceeac02
UpToDate, Wolters Kluwer Health - 2013-02-19
Press Mentions
- Federman Named Chief of Medicine, Vice Chair for Veterans AffairsJanuary 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: